Increasing valuation for healthcare operations companies
How to rethink competitive moats, build enduring advantage against well-funded AI platforms, and move from EBITDA multiples to revenue multiples in three years.
The gap between a 4-7x EBITDA exit and a 5x revenue exit is not about growth rate. It is about how defensible your operation looks to the acquirer.
Agenda
What we will cover
The competitive moat question
What happens to your defensibility when a general-purpose AI agent can do 80% of what your billers do today. Where the remaining 20% creates durable advantage, and how to build around it.
Margin structure under AI pressure
The specific mechanisms by which AI compresses your operating margins, and the counter-moves that expand them. We bring real data from operations we have mapped.
From EBITDA to revenue multiples
What separates a 4-7x EBITDA exit from a 5x revenue exit. The operational metrics that move your multiple, and a 3-year framework for getting there.
Context
Why this conversation matters now
The healthcare operations industry is consolidating faster than most operators realize. AI-native entrants are not competing on price. They are competing on cost structure. The companies that understand their own margin architecture, and rebuild the defensible parts of it around AI, will set the terms of the next wave of acquisitions.
This is the conversation the acquirers are already having. You should be having it first.
Seats are limited to 50
We keep the group small so the conversation stays useful. If the session fills, register for the waitlist and we will notify you of the next one.
Reserve your seat